A new way to prevent HIV delivers dramatic results in trial
Lenacapavir injection proved more effective than daily PrEP pills, showing promise for HIV prevention among women in sub-Saharan Africa.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
Experts say a twice-yearly injection that offers 100 percent protection against HIV is 'stunning'
Twice-yearly shots for AIDS were 100 percent effective in preventing infections in women, with high potential for broader use as a preventative measure.
Doctor behind trial of HIV prevention drug recounts breakthrough moment
A new HIV prevention drug, lenacapavir, showed 100% protection for women aged 16 to 25 in South Africa and Uganda.
Humanity is closer to stopping HIV, and the biggest obstacle is the price of the drug that will do it
Lenacapavir shows 100% efficacy in preventing HIV infections in women with simple administration.
It is not a vaccine but highly effective, sparking enthusiasm in the fight against HIV.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ Nation
Lenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
A new way to prevent HIV delivers dramatic results in trial
Lenacapavir injection proved more effective than daily PrEP pills, showing promise for HIV prevention among women in sub-Saharan Africa.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
Experts say a twice-yearly injection that offers 100 percent protection against HIV is 'stunning'
Twice-yearly shots for AIDS were 100 percent effective in preventing infections in women, with high potential for broader use as a preventative measure.
Doctor behind trial of HIV prevention drug recounts breakthrough moment
A new HIV prevention drug, lenacapavir, showed 100% protection for women aged 16 to 25 in South Africa and Uganda.
Humanity is closer to stopping HIV, and the biggest obstacle is the price of the drug that will do it
Lenacapavir shows 100% efficacy in preventing HIV infections in women with simple administration.
It is not a vaccine but highly effective, sparking enthusiasm in the fight against HIV.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ Nation
Lenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
Beginning of end of HIV epidemic? - Harvard Gazette
Researchers are cautiously optimistic about a new preventative treatment for the AIDS virus, lenacapavir, showing promising results in preventing infection.